Skip to main content

Supplementary Tables 1 from Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201)

Publication ,  Other
Jensen, JL; Bobek, O; Chan, ICC; Miller, BC; Hillman, DW; Heller, G; Druley, T; Armstrong, AJ; Morris, MJ; Milowsky, MI; Beltran, H ...
November 1, 2024

<p>Supplementary Tables</p>

Duke Scholars

DOI

Publication Date

November 1, 2024
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jensen, J. L., Bobek, O., Chan, I. C. C., Miller, B. C., Hillman, D. W., Heller, G., … Coombs, C. C. (2024). Supplementary Tables 1 from Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201). https://doi.org/10.1158/1078-0432.27434243
Jensen, Jeffrey L., Olivia Bobek, Irenaeus C. C. Chan, Brian C. Miller, David W. Hillman, Glenn Heller, Todd Druley, et al. “Supplementary Tables 1 from Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201),” November 1, 2024. https://doi.org/10.1158/1078-0432.27434243.
Jensen JL, Bobek O, Chan ICC, Miller BC, Hillman DW, Heller G, Druley T, Armstrong AJ, Morris MJ, Milowsky MI, Beltran H, Bolton KL, Coombs CC. Supplementary Tables 1 from Clonal Hematopoiesis and Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer Patients Given Androgen Receptor Pathway Inhibitors (Alliance A031201). 2024.

DOI

Publication Date

November 1, 2024